Oracea (40mg doxycycline)

Oracea is a once per day 40mg (30mg immediate release and 10mg delayed release) doxycycline treatment for the papules and pustles of rosacea. Galderma promote Oracea as superior to 50mg a day of generic doxycycline because Oracea is a low enough dose to be promoted as an `anti-inflamatory only’ treatment and not suffering from potential problems of higher doses of antibiotics.

Be sure to checkout the Oracea User Reviews.

Recent Rosacea Blog Posts

Oracea and Finacea prescription prices are increasing !

The JAMA Dermatology has just published a summary of the trend in prescription prices from 2009 to 2015. The news is not good. Overall the brand-name prescriptions increased in price FOUR FOLD during this period. Four national chain pharmacies in the West Palm Beach, Florida, area—specifically, Costco, CVS, Sam’s Club, and Walgreens—were initially surveyed in […]

Continue Reading

Its official–Mirvaso, Soolantra and Oracea make the grade as proven rosacea treatments

The just published update to the 2011 Cochrane review of interventions for rosacea has given its opinion on the last 4 years of published rosacea research. Previous Cochrane reviews on rosacea interventions have been published in 2004, 2005 and 2011. This review looked at 106 randomized clinical trials with 13,631 participants. Cochrane Review Results The […]

Continue Reading

Say goodbye to Generic Oracea

A recent ruling from the U.S. Patent and Trademark Office has put the final nail in coffin of the hopes for the availability of Generic Oracea. Rosacea sufferers will need to wait until that late 2020’s until the current patents protecting Oracea expire. Concerted efforts from Amneal Pharmaceuticals and Mylan Inc. have both failed to […]

Continue Reading

Step backwards for Generic Oracea. Invalid patents are back

For those following the saga of the possible availability of Generic Oracea in the future, another twist today. Two of the patents that were previously ruled invalid and thus unable to protect Galderma’s product, have now been ruled no longer invalid. This legal ruling will no doubt embolden Galderma that their profitable product Oracea can […]

Continue Reading

Generic Oracea one step closer, Lupin gets Tentative FDA Approval

News today that Lupin has been granted tentative approval by the FDA to product a generic version of Oracea. We learn in 2010 that Lupin had filed an abbreviated new drug application to make generic Oracea. Lupin Pharmaceuticals, based in Mumbai India,  is a company specialising in the production of generic medicines. It has been […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.